This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: NOK BBRY PFE NDAQ VZ CCE

Darden (DRI) estimates cut at Sterne Agee through 2015, Sterne Agee said. Industry sales trends have been weak. Buy rating and $55 price target.

Guidewire (GWRE) numbers raised at UBS. GWRE earnings estimates were raised given momentum from sales force productivity and deal wins, said UBS. Price target is boosted to $52.

Micron (MU) estimates increased at Lazard through 2014, Lazard Capital Markets said. Management remained positive about the DRAM market on a recent roadshow. Neutral rating.

Pfizer (PFE - Get Report) estimates, target boosted at Leerink. Shares of PFE now seen reaching $28.50, according to Leerink Swann. Estimates also upped, given higher international Lyrica sales and cost cutting. Market Perform rating.

Rowan (RDC) estimates reduced at Jefferies to reflect a modest equipment-related delivery delay on the Renaissance ship, said Jefferies. Price target is $42.

[READ: <a target="BLANK" data-add-tracking="TRUE" href="http://www.mainstreet.com/slideshow/career/my-biggest-work-mistake-7-career-confessions"><em>'My Biggest Work Mistake': 7 Career Confessions</em></a>]

Rosetta Resources (ROSE) added to Best Ideas List at Wunderlich. Company is ramping production, but trades at a discount to peers.

Verizon (VZ - Get Report) estimates, target raised at Oppenheimer. Shares of VZ now seen reaching $56, according to Oppenheimer. Estimates also increased, following the wireless buyout. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BBRY $7.37 2.50%
NOK $6.32 0.00%
NDAQ $51.49 0.37%
PFE $32.66 -1.80%
VZ $46.07 -0.26%

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs